Shares of Verici Dx plc (LON:VRCI – Get Free Report) rose 31.8% during mid-day trading on Thursday . The company traded as high as GBX 3.63 ($0.05) and last traded at GBX 3.63 ($0.05). Approximately 959,982 shares traded hands during trading, an increase of 65% from the average daily volume of 581,209 shares. The stock had previously closed at GBX 2.75 ($0.04).
Verici Dx Stock Performance
The company’s 50-day simple moving average is GBX 3.76 and its 200 day simple moving average is GBX 4.34. The company has a current ratio of 4.54, a quick ratio of 8.49 and a debt-to-equity ratio of 4.64. The stock has a market cap of £10.93 million, a P/E ratio of -2.09 and a beta of 1.59.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Stories
- Five stocks we like better than Verici Dx
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Broaden Your ETF Exposure With These 3 Overlooked Funds
- 3 Warren Buffett Stocks to Buy Now
- 2 Stocks Insiders Are Buying and 1 They’re Selling
- Expert Stock Trading Psychology Tips
- 2 Must-Have Stocks as Consumers Prioritize Needs Over Wants
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
